Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

US Patent 9790204 · Granted Oct 17, 2017

Estimated economic value: $4,489,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Parenterally administered immune enhancing drugs2025
Parenterally administered immune enhancing drugs2025
Amorphous and crystalline forms of IDO inhibitors2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
Thiazole compounds and methods of use thereof2025
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases2025
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors2025